AMRI has entered into a preferred provider agreement with BioPontis Alliance LLC to support BioPontis’ efforts to bridge the gap between early stage research and newly-discovered technologies developed in academia and other research entities. AMRI will provide its services in small molecule discovery, development, and manufacturing for BioPontis’ research programs. The agreement also supports proof-of-concept data. The goal of the alliance is to identify promising early stage product opportunit...